Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
- 1 May 2000
- Vol. 55 (5) , 694-699
- https://doi.org/10.1016/s0090-4295(99)00585-3
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOINGJournal of Urology, 1999
- Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2Biochemical and Biophysical Research Communications, 1997
- Characterization of the Precursor of Prostate-specific AntigenJournal of Biological Chemistry, 1997
- Human glandular kallikrein 2 (hK2) expression in prostatic intraepithelial neoplasia and adenocarcinoma: A novel prostate cancer markerUrology, 1997
- Clinical utility of measurement free and total prostate-specific antigen (PSA): A reviewThe Prostate, 1996
- Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate CancerJournal of Urology, 1993
- Tissue-specific and hormonal regulations of human prostate-specific glandular kallikreinBiochemistry, 1992
- Expression of the gene coding for human prostate‐specific antigen and related hGK‐1 in benign and malignant tumors of the human prostateInternational Journal of Cancer, 1990
- High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate‐specific antigenFEBS Letters, 1988
- Primary Structure of a Human Glandular Kallikrein GeneDNA, 1987